TNF and neoplasm: Interestingly, by using an anti-PD-1 antibody or a recombinant PD-L1 molecule, the production of IFN-γ and TNF-α was inhibited, suggesting that, in the tumor microenvironment, the anti-tumor activity of ILC3s could be repressed because of their PD-1 expression.